Fractyl Health Inc. (NASDAQ: GUTS)
$2.1600
+0.1000 ( +3.85% ) 217.7K
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.